Summary
Regenerative medicine using growth factors is an important therapeutic tool in patients with tissue ischemia or defects. Among such therapies, we have mainly addressed the sustained release of basic fibroblast growth factor (bFGF) as a safe and effective treatment. We developed a biodegradable hydrogel composed of acidic gelatin to enable bFGF to be released at the site of action for a sufficient time period. We experimentally applied this method in various animal models for cardiovascular research with satisfactory results as follows: 1) Sustained release of bFGF from gelatin hydrogel is effective in ischemic heart disease, dilated cardiomyopathy, pulmonary hypertension, limb ischemia, and bone regeneration; 2) Both sustained release of bFGF and bone marrow cell transplantation induce angiogenesis, but only bFGF produces arteriogenesis; 3) bFGF increases efficacy of cell transplantation, such as cardiomyocyte or skeletal myoblast. Future study is warranted for safe and effective clinical applications of the bFGF controlled-release system.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Iwakura A, Tabata Y, Tamura N, Doi K, Nishimura K, Nakamura T, Shimizu Y, Fujita M, Komeda M (2001) Gelatin sheet incorporating basic fibroblast growth factor enhances healing of devascularized sternum in diabetic rats. Circulation 104[Suppl I]: I-325–I-329
Iwakura A, Tabata Y, Koyama T, Doi K, Nishimura K, Kataoka K, Fujita M, Komeda M (2003) Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteries. J Thorac Cardiovasc Surg 126:1113–20
Marui A, Tabata Y, Doi K, Iwakura A, Hirose K, Yamamoto M, Kushibiki T, Nishina T, Ikeda T, Nishimura K, Komeda M (2003) Novel method to induce therapeutic angiogenesis in critical limb ischemia with use of basic fibroblast growth factor-incorporated gelatin hydrogel. Atherosclerosis Supplement 4:171
Rifkin DB, Moscatelli D (1989) Recent development in the cell biology of basic fibroblast growth factor. J Cell Biol 109:1–6
Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata Y, Komeda M (2002) Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 124:50–56
Sakakibara Y, Tambara, K. Sakaguchi G, Komeda M (2002) Which is a more effective angiogenic therapy, bone marrow cell transplantation or control-released basic fibroblast growth factor administration? Circulation 106[Suppl II]: II–419
Sakakibara Y, Tambara K, Sakaguchi G, Lu F, Yamamoto M, Nishimura K, Tabata Y, Komeda M (2003) Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg 24:105–11; discussion 112
Tabata Y, Hijikata S, Ikada Y (1994) Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Control Release 31:189–199
Tabata Y, Yamada K, Miyamoto S, Nagata I, Kikuchi H, Aoyama I, Tamura M, Ikada Y (1998) Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels. Biomaterials 19(7–9):807–815
Tabata Y, Ikada Y (1998) Protein release from gelatin matrices. Adv Drug Deliv Rev 31:287–301
Tambara K, Horii T, Premaratne GU, Sakakibara Y, Yamamoto M, Ozeki M, Tabata Y, Nishimura K (2003) Epicardial administration of control-released basic fibroblast growth factor induces angiogenesis and improves left ventricular function in dilated cardiomyopathy. Circulation 108[Suppl IV]: IV–399
Tambara K, Premaratne GU, Sakakibara Y, Nakajima H, Lu F, Kanemitsu N, Yamamoto M, Ozeki M, Tabata Y (2003) Simultaneous administration of control-released basic fibroblast growth factor enhances the efficacy of skeletal myoblast transplantation by increasing vascular density and graft volume. Circulation 108[Suppl IV]: IV–332
Ueyama K, Gaobing, Tabata Y, Ozeki M, Doi K, Nishimura K, Suma H, Komeda M (2004) Development of biologic coronary artery bypass grafting in a rabbit model: Revival of a classic concept with modern biotechnology. J Thorac Cardiovasc Surg 127:1608–1615
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Marui, A. et al. (2005). Basic Fibroblast Growth Factor and Angiogenesis. In: Mori, H., Matsuda, H. (eds) Cardiovascular Regeneration Therapies Using Tissue Engineering Approaches. Springer, Tokyo. https://doi.org/10.1007/4-431-27378-6_12
Download citation
DOI: https://doi.org/10.1007/4-431-27378-6_12
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-23925-3
Online ISBN: 978-4-431-27378-3
eBook Packages: MedicineMedicine (R0)